Company description
Antibody-based therapies have achieved remarkable success in various human diseases, including cancer, viral infections, autoimmune diseases, and degeneration diseases. The clinical efficacy of most marketed and under-development antibody drugs results primarily from their ability to elicit cytotoxicity potencies via Fc-mediated functions. Creative Biolabs has successfully integrated a full range of well-established assays for precisely elaborating functional profiles of therapeutic antibodies. In particular, we have strong confidence in delivering the most comprehensive services of determining antibody-receptor binding affinity as well as the mechanism of action regarding antibody-dependent, Fc-mediated immune effector function.
